PDCD1 and paraneoplastic neurologic syndrome: This was a retrospective descriptive study involving 224 patients with PD-1/PD-L1 inhibitor–related PNS from May 2015 to May 2025, including 8 patients who presented at our hospital and 216 patients reported in the literature.